Safety Analysis of Co-Administration of Radiation Therapy with Enfortumab Vedotin Based Regimens in Metastatic Urothelial Carcinoma
This study demonstrates that co-administration of RT with EV-based regimens could be safe and effective for symptom palliation. Larger series examining this treatment combination are needed.
Authors
- Mitra Daneshvar (ORCID: https://orcid.org/0000-0002-2333-1932)
- Guilherme Harada (ORCID: https://orcid.org/0000-0003-4012-3251)
- Arash Rezazadeh Kalebasty
- Nataliya Mar (ORCID: https://orcid.org/0000-0003-2485-6201)
- Dalia Kaakour (ORCID: https://orcid.org/0000-0003-2985-9591)
- Steven N. Seyedin (ORCID: https://orcid.org/0000-0002-6841-968X)
- Sami Dwabe (ORCID: https://orcid.org/0009-0007-4959-7652)
- Eleen Garemanian
- Desiree Rafizadeh
Institutions
- University of California, San Francisco (US)
- University of California, Irvine (US)
- University of California, Irvine Medical Center (US)
- University of California San Francisco Medical Center (US)
- UC Irvine Health (US)
Publication Details
- Journal
- Clinical Genitourinary Cancer
- Published
- 2024-10-18
- DOI
- https://doi.org/10.1016/j.clgc.2024.102243
- Citations
- 4
- Primary Topic
- Bladder and Urothelial Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 2.29
Funders
- Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco